Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Debio-4228 by Debiopharm International for Metastatic Prostate Cancer: Likelihood of Approval
Debio-4228 is under clinical development by Debiopharm International and currently in Phase II for Metastatic Prostate Cancer. According to GlobalData,...